Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,707,863
+$2,496,820 QoQ
Shares Held
118,057
-5.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#490
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. ABBV ranks #4 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,707,863 | 118,057 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $27,211,043 | 125,114 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $31,235,725 | 136,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,591,360 | 145,078 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $22,050,356 | 118,793 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $32,122,558 | 153,315 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $34,731,465 | 195,450 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $37,338,531 | 189,075 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,554,229 | 178,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,495,745 | 178,450 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $22,778,885 | 146,989 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $21,938,054 | 147,176 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $25,446,859 | 188,873 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $23,360,295 | 146,579 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $23,449,449 | 145,099 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $15,051,248 | 112,147 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $17,228,202 | 112,485 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $14,490,688 | 89,388 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $12,087,699 | 89,274 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $4,221,923 | 39,139 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $1,311,918 | 11,647 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $3,895,162 | 35,993 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $4,047,484 | 37,774 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $3,534,168 | 40,349 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $4,954,850 | 50,467 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $2,617,583 | 34,356 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||